Increased R&D lowers profitability in FY18; conservative outlook for the next year
20/02/19 -"Impacted by higher production costs, increased investments into R&D and slower organic growth in the retail business, the adjusted EBIT came in at the lower end of the guidance range for FY18. ..."
Pages
58
Language
English
Published on
20/02/19
You may also be interested by these reports :
22/03/24
We have included the announced 1,000-to-1 reverse stock split into our number of shares, following the effectiveness of the share consolidation and ...
22/03/24
We have maintained our assumption and the company’s plan of a €300m capital increase to be completed in 2024, but with an expected subscription price ...
21/03/24
Bastide’s half-year turnover and EBITDA both saw decent yoy growth despite heavier payroll costs, while the underlying operating margin moderately ...
18/03/24
DiaSorin’s 2023 results were in line with street expectations, however the profitability guidance miss disappointed investors. Healthy performance by ...